Peptides and Anti-Doping: WADA Status Explained

If you play a sport that drug-tests its athletes, the peptide question has a pretty clear answer: a lot of the popular research peptides are banned, many of them all year round, and a failed test can keep you out of your sport for years. (WADA, the World Anti-Doping Agency, writes the rulebook that most tested sports follow.) This guide walks through where peptides fall on WADA’s banned list and what each group actually means. It is not medical or legal advice.

The Prohibited List is built around categories, not brand names

Every year WADA puts out a Prohibited List, which is just the official roster of banned substances. The current one started on January 1, 2026. The list sorts everything into groups, labeled S0 through S9, plus a set of banned methods. Here is the key part: a substance is banned if it fits one of those groups, even if its exact name is not printed anywhere. For the peptide groups, the list bans the named substances “and other substances with similar chemical structure or similar biological effect(s).” So if your peptide is not on the list by name, that does not mean it is allowed.

There are also two kinds of timing to keep straight. Some substances are prohibited at all times, meaning they are banned every day of the year, whether or not you are competing. Others are prohibited in-competition only, meaning they are banned just during the competition window. The Code defines that window as starting at 11:59 p.m. the night before a competition and running through the end of the event and the sample-collection that follows. The peptide groups that matter to most people reading this are the all-times kind.

S2: peptide hormones, growth factors, and their releasing factors

S2 is where most of the well-known peptides live, and it is banned at all times. On the 2026 List, S2 is laid out like this:

Erythropoietins (EPO) and agents affecting erythropoiesis (S2.1) — these affect how your body makes red blood cells. This covers EPO receptor agonists, HIF-activating agents, and related substances.
Peptide hormones and their releasing factors (S2.2), which includes:
- Peptides that push the body to make more testosterone in males, for example chorionic gonadotrophin (CG), luteinizing hormone (LH), GnRH (gonadorelin) and its close chemical cousins (its agonist analogues), and kisspeptin.
- Corticotrophins and the substances that trigger their release.
- Growth hormone (GH), its analogues and fragments — that is, GH itself, look-alike versions of it, and small pieces of it (for example AOD-9604, hGH 176-191).
- Growth hormone releasing factors — the substances that tell the body to release growth hormone. This includes GHRH and its analogues (for example CJC-1293, CJC-1295, sermorelin, tesamorelin), GH secretagogues such as ipamorelin (and ibutamoren/MK-677, anamorelin, and others), and GH-releasing peptides (GHRPs) such as hexarelin, GHRP-1, GHRP-2 (pralmorelin), and GHRP-6.
Growth factors and growth factor modulators (S2.3) — these are substances that affect tissue growth and repair. The group covers IGF-1 and its analogues, mechano growth factors (MGFs), fibroblast growth factors, hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), and any growth factor that affects how muscle, tendon, or ligament rebuilds protein, grows new blood vessels, or heals. Thymosin-β4 and its derivatives, including TB-500, are named here by name.

The plain takeaway: the “healing” and “GH-boosting” peptides that get marketed to athletes are mostly S2, and they are banned at all times.

S0: non-approved substances (where BPC-157 lives)

S0 is a catch-all for any drug that does not fit another section of the list and “with no current approval by any governmental regulatory health authority for human therapeutic use.” In other words, no health authority anywhere has signed off on it for treating people. That covers drugs still in early or clinical testing, drugs that were pulled from the market, designer drugs, and things approved only for use in animals. On the 2026 List, BPC-157 is named as an example of an S0 substance, and it is banned at all times. USADA (the U.S. Anti-Doping Agency) says the same thing — that BPC-157 is banned under S0 and “is not approved for human clinical use by any global regulatory authority.” Because nothing in S0 has an approved medical use, the medical-exemption process explained below is realistically not an option for these.

S4: hormone and metabolic modulators

A few peptide-related compounds show up in S4, which is also banned at all times. The two parts most likely to matter here are:

Agents preventing activin receptor IIB activation (S4.3) — these block a pathway that limits muscle growth, often called myostatin inhibitors. The group includes myostatin-binding proteins such as follistatin and myostatin propeptide, antibodies that neutralize myostatin or its precursor, and decoy activin receptors such as ACE-031.
Metabolic modulators (S4.4) — substances that change how the body handles energy. This includes AMPK activators such as AICAR and the mitochondrially derived peptide MOTS-c.

Therapeutic Use Exemptions (TUEs)

A TUE (Therapeutic Use Exemption) is official permission for an athlete to use a banned substance because they genuinely need it for a medical condition. Under WADA’s rules for TUEs, all four of these have to be true: the substance treats a diagnosed condition backed by real clinical evidence; it would not boost your performance beyond simply getting you back to normal health; there is no reasonable allowed alternative you could use instead; and your need did not come from having used a banned substance earlier without a TUE. You have to apply with detailed medical paperwork, and an independent TUE Committee reviews it. They are expected to make a decision within 21 days of getting a complete application. Substances with no approved medical use — which describes most of the S0 research peptides — realistically cannot qualify.

Bottom line

In drug-tested sport, treat a peptide as banned until you have personally checked and confirmed it is not. EPO, growth hormone and the peptides that release it (GHRH analogues, GHRPs, ipamorelin), growth factors like TB-500, myostatin-related agents, and unapproved peptides like BPC-157 are all banned — most of them at all times — and many come with bans of several years. Look up each specific substance and product on Global DRO (keep in mind it does not cover dietary supplements), and if you have a real medical need, go through the TUE process before you use anything, not after a failed test.

Sources

New profiles and evidence updates only. No spam, and we never sell or share your email.